University Of Washington Receives $3.5 Million In Federal Funds To Establish Multiple Sclerosis Research And Training Center

September 24, 1998

The University of Washington has received notification from the National Institute on Disability and Rehabilitation Research that it will receive $3.5 million for a Multiple Sclerosis (MS) Research and Training Center, renewable every five years.

"UW Medical Center has had a Multiple Sclerosis Clinic for 21 years and has a long record of research into MS," said Dr. George Kraft, professor of rehabilitation medicine, who will head the new center. "This grant will allow us to greatly expand our research into the optimum methods of treating people with MS."

Kraft noted the Northwest has a very high prevalence of MS, so it is appropriate that the new center be located in Seattle. The UW competed for the funding, which had been awarded for the past 15 years to Albert Einstein Medical College in New York.

UW Medical Center's MS Clinic currently treats more than 750 patients. With the new grant, 1,200 MS patients will be enrolled in various research studies proposed for the grant. They will be drawn from the five-state WWAMI region served by the UW School of Medicine (Washington, Wyoming, Alaska, Montana and Idaho), as well as Hawaii.

A major goal, said Kraft, is to develop and evaluate various strategies for improving the care and functioning of people with MS. The researchers will investigate the benefits of early identification of the disease and prompt treatment of psychological distress, such as depression, and the effects of employment issues and aging on persons with MS. They will also investigate differences in the incidence of MS as influenced by people's ethnic, cultural, geographic and health care backgrounds.

The MS Clinic will be expanded, with the addition of patient counselors who provide increased access for patients, including telephone counseling. A menu of specific wellness activities will be developed to address some of the issues people face in managing their illness.

Kraft and his colleagues plan to utilize professional contacts with physicians throughout the WWAMI region, as well as Medcon, the UW's free consulting service for physicians, to allow patients to remain in their home communities for evaluation, rehabilitation and treatment.

The addition of patients from Hawaii is noteworthy, said Kraft, because of the much greater incidence of MS in temperate climates compared to incidence in the tropics. The incidence is about 150 cases per 100,000 population in Washington, versus just 58 per 100,000 in Florida.

"We know the prevalence is based not just on where you live, but on where you grew up," said Kraft. "MS is caused by something acquired during the first 15 years of life." The majority of MS cases in Hawaii, for example, are among Caucasians who moved there after childhood. Researchers think the disease is caused by environmental factors -- viral or bacterial assaults on the immune system -- combined with a receptive genetic background.

The MS Clinic and the new MS Research and Training Center are administered by the UW's Department of Rehabilitation Medicine, which was ranked second in the nation in the latest U.S. News & World Report hospital rankings.

University of Washington

Related Multiple Sclerosis Articles from Brightsurf:

New therapy improves treatment for multiple sclerosis
A new therapy that binds a cytokine to a blood protein shows potential in treating multiple sclerosis, and may even prevent it.

'Reelin' in a new treatment for multiple sclerosis
In an animal model of multiple sclerosis (MS), decreasing the amount of a protein made in the liver significantly protected against development of the disease's characteristic symptoms and promoted recovery in symptomatic animals, UTSW scientists report.

Not all multiple sclerosis-like diseases are alike
Scientists say some myelin-damaging disorders have a distinctive pathology that groups them into a unique disease entity.

New therapeutic options for multiple sclerosis in sight
Strategies for treating multiple sclerosis have so far focused primarily on T and B cells.

Diet has an impact on the multiple sclerosis disease course
The short-chain fatty acid propionic acid influences the intestine-mediated immune regulation in people with multiple sclerosis (MS).

The gut may be involved in the development of multiple sclerosis
It is incompletely understood which factors in patients with multiple sclerosis act as a trigger for the immune system to attack the brain and spinal cord.

Slowing the progression of multiple sclerosis
Over 77,000 Canadians are living with multiple sclerosis, a disease whose causes still remain unknown.

7T MRI offers new insights into multiple sclerosis
Investigators from Brigham and Women's Hospital have completed a new study using 7 Tesla (7T) MRI -- a far more powerful imaging technology -- to further examine LME in MS patients

How to improve multiple sclerosis therapy
Medications currently used to treat multiple sclerosis (MS) can merely reduce relapses during the initial relapsing-remitting phase.

Vaccinations not a risk factor for multiple sclerosis
Data from over 12,000 multiple sclerosis (MS) patients formed the basis of a study by the Technical University of Munich (TUM) which investigated the population's vaccination behavior in relation to MS.

Read More: Multiple Sclerosis News and Multiple Sclerosis Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to